Lista de obras - Mark Crowther - Dominio Público Uruguay

A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia

artículo científico publicado en 2012

Antiphospholipid Syndrome: A Challenging Hypercoagulable State with Systemic Manifestations

scientific article published on 01 August 2010

Aspirin in secondary prevention of recurrent venous thromboembolism

artículo científico publicado en 2015

Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial

artículo científico publicado en 2013

Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta-analysis

artículo científico publicado en 2017

Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study establishing diagnostic criteria and prognostic importance

artículo científico publicado en 2020

Bleeding impacting mortality after noncardiac surgery: a protocol to establish diagnostic criteria, estimate prognostic importance, and develop and validate a prediction guide in an international prospective cohort study

artículo científico publicado en 2017

Clinically important deep vein thrombosis in the intensive care unit: a survey of intensivists

artículo científico publicado en 2004

Comment on: editorial by Husted et al. "Non-vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel". (Thromb Haemost 2014; 111: 781-782)

Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients

artículo científico publicado en 2015

Dalteparin versus Unfractionated Heparin in Critically Ill Patients

artículo científico publicado en 2011

Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors

artículo científico publicado en 2005

Deep venous thrombosis: clinically silent in the intensive care unit

artículo científico publicado en 2005

Definition of major bleeding used by US anticoagulation clinics

artículo científico publicado en 2008

Detecting myocardial infarction in critical illness using screening troponin measurements and ECG recordings

artículo científico publicado en 2008

Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura (ITP).

scientific article published on May 2011

Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis

scientific article published on 01 October 2020

Evaluating the quality of systematic reviews and meta-analyses published on direct oral anticoagulants in the past 5 years

scientific article published on 03 June 2020

Evidence and clinical judgment: vena cava filters

artículo científico publicado en 2014

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*.

artículo científico publicado en 2015

GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy

scientific article published on 12 February 2020

GRADE guidelines: 21 part 2. Test accuracy: inconsistency, imprecision, publication bias, and other domains for rating the certainty of evidence and presenting it in evidence profiles and summary of findings tables

artículo científico publicado en 2020

Heparin-induced thrombocytopenia in medical surgical critical illness

artículo científico publicado en 2013

Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial

artículo científico publicado en 2014

Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil

artículo científico publicado en 2011

Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, Brazil

artículo científico publicado en 2012

Hot topics in parenteral nutrition. A review of the use of glutamine supplementation in the nutritional support of patients undergoing bone-marrow transplantation and traditional cancer therapy

scientific article published on 24 June 2009

How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based review

artículo científico publicado en 2007

Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy

artículo científico publicado en 2008

Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial

artículo científico publicado en 2008

Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants: A Systematic Review

artículo científico publicado en 2016

Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants.

artículo científico publicado en 2014

Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin

Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial

artículo científico publicado en 2018

Methodology for guideline development for the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

artículo científico publicado en 2004

Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia

artículo científico publicado en 2010

Mortality outcomes in patients transfused with fresher versus older red blood cells: a meta-analysis.

artículo científico publicado en 2017

Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes

artículo científico publicado en 2014

Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients

artículo científico publicado en 2004

Newer anticoagulants in critically ill patients

artículo científico publicado en 2012

Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide

scientific article published on 12 May 2020

Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan

artículo científico publicado en 2011

Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism.

artículo científico publicado en 2010

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

artículo científico publicado en 2008

Postdischarge venous thromboembolic complications following pulmonary oncologic resection: An underdetected problem

artículo científico publicado en 2015

Practice patterns in venous thromboembolism (VTE) prophylaxis in thoracic surgery: a comprehensive Canadian Delphi survey

artículo científico publicado en 2017

Preoperative prediction of Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study

artículo científico publicado en 2020

Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention

artículo científico publicado en 2009

Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment

artículo científico publicado en 2009

Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study

artículo científico publicado en 2008

Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study

artículo científico publicado en 2005

Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia

artículo científico publicado en 2018

Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate.

artículo científico publicado en 2012

Rapid quantitativeD-dimer to exclude pulmonary embolism: a prospective cohort management study

artículo científico publicado en 2016

Red blood cell storage and in-hospital mortality: a secondary analysis of the INFORM randomised controlled trial

artículo científico publicado en 2017

Response to Dr Junqueira

artículo científico publicado en 2013

Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and

artículo científico publicado en 2013

Severe hemolytic anemia post-renal transplantation produced by donor anti-D passenger lymphocytes: case report and literature review

artículo científico publicado en 2009

Specific antidotes for bleeding associated with direct oral anticoagulants

artículo científico publicado en 2017

Systematic review of anticoagulant treatment of catheter-related thrombosis

artículo científico

The "parallel-cohort RCT": Novel design aspects and application in the Kids-DOTT trial of pediatric venous thromboembolism

artículo científico publicado en 2009

The Khorana score for prediction of venous thromboembolism in cancer patients: an individual patient data meta-analysis

scientific article published on 26 April 2020

The Reply

The clinical consequence of subtherapeutic anticoagulation: the low INR study (LINeRS)

The diagnosis of myocardial infarction in critically ill patients: an agreement study.

artículo científico publicado en 2009

The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin. A randomised trial

artículo científico publicado en 2016

The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis

artículo científico publicado en 2014

The metabolic syndrome and the risk of venous thrombosis: a case–control study

artículo científico publicado en 2006

The risk of venous thromboembolism in patients with clinically overt gastrointestinal bleeding

artículo científico publicado en 2017

The vexing problem of guidelines and conflict of interest: a potential solution

artículo científico publicado en 2010

Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors

artículo científico publicado en 2005

Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.

artículo científico publicado en 2005

Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit

artículo científico publicado en 2014

Treatment of Antiphospholipid Antibody Syndrome—Reply

artículo científico publicado en 2006

Uncertainties in baseline risk estimates and confidence in treatment effects

artículo científico publicado en 2012

Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials

artículo científico publicado en 2008

Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

scientific article published on 01 September 2020

Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol

artículo científico publicado en 2016

Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors

artículo científico publicado en 2008

Venous thromboembolism prophylaxis in critically ill patients

artículo científico publicado en 2015

Lista de obras de Mark Crowther

A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia

Antiphospholipid Syndrome: A Challenging Hypercoagulable State with Systemic Manifestations

Aspirin in secondary prevention of recurrent venous thromboembolism

Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial

Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta-analysis

Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study establishing diagnostic criteria and prognostic importance

Bleeding impacting mortality after noncardiac surgery: a protocol to establish diagnostic criteria, estimate prognostic importance, and develop and validate a prediction guide in an international prospective cohort study

Clinically important deep vein thrombosis in the intensive care unit: a survey of intensivists

Comment on: editorial by Husted et al. "Non-vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel". (Thromb Haemost 2014; 111: 781-782)

Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients

Dalteparin versus Unfractionated Heparin in Critically Ill Patients

Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors

Deep venous thrombosis: clinically silent in the intensive care unit

Definition of major bleeding used by US anticoagulation clinics

Detecting myocardial infarction in critical illness using screening troponin measurements and ECG recordings

Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura (ITP).

Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis

Evaluating the quality of systematic reviews and meta-analyses published on direct oral anticoagulants in the past 5 years

Evidence and clinical judgment: vena cava filters

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*.

GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy

GRADE guidelines: 21 part 2. Test accuracy: inconsistency, imprecision, publication bias, and other domains for rating the certainty of evidence and presenting it in evidence profiles and summary of findings tables

Heparin-induced thrombocytopenia in medical surgical critical illness

Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial

Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil

Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, Brazil

Hot topics in parenteral nutrition. A review of the use of glutamine supplementation in the nutritional support of patients undergoing bone-marrow transplantation and traditional cancer therapy

How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based review

Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy

Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial

Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants: A Systematic Review

Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants.

Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin

Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial

Methodology for guideline development for the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia

Mortality outcomes in patients transfused with fresher versus older red blood cells: a meta-analysis.

Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes

Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients

Newer anticoagulants in critically ill patients

Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide

Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan

Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism.

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Postdischarge venous thromboembolic complications following pulmonary oncologic resection: An underdetected problem

Practice patterns in venous thromboembolism (VTE) prophylaxis in thoracic surgery: a comprehensive Canadian Delphi survey

Preoperative prediction of Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study

Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention

Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment

Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study

Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study

Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia

Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate.

Rapid quantitativeD-dimer to exclude pulmonary embolism: a prospective cohort management study

Red blood cell storage and in-hospital mortality: a secondary analysis of the INFORM randomised controlled trial

Response to Dr Junqueira

Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and

Severe hemolytic anemia post-renal transplantation produced by donor anti-D passenger lymphocytes: case report and literature review

Specific antidotes for bleeding associated with direct oral anticoagulants

Systematic review of anticoagulant treatment of catheter-related thrombosis

The "parallel-cohort RCT": Novel design aspects and application in the Kids-DOTT trial of pediatric venous thromboembolism

The Khorana score for prediction of venous thromboembolism in cancer patients: an individual patient data meta-analysis

The Reply

The clinical consequence of subtherapeutic anticoagulation: the low INR study (LINeRS)

The diagnosis of myocardial infarction in critically ill patients: an agreement study.

The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin. A randomised trial

The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis

The metabolic syndrome and the risk of venous thrombosis: a case–control study

The risk of venous thromboembolism in patients with clinically overt gastrointestinal bleeding

The vexing problem of guidelines and conflict of interest: a potential solution

Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors

Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.

Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit

Treatment of Antiphospholipid Antibody Syndrome—Reply